Investing10d
Trinity Biotech secures US funding for HIV tests
Trinity Biotech's two rapid HIV tests will continue to be funded under PEPFAR, a significant global initiative to combat HIV/AIDS. The company confirmed that other testing programs using their ...
Investing10d
Trinity Biotech secures US funding for HIV tests
DUBLIN, Ireland - Trinity Biotech plc (NASDAQ:TRIB), a leading provider of diagnostic solutions for the healthcare industry, today announced the continuation of U.S. government funding for its HIV ...
Hosted on MSN10d
Trinity Biotech Secures Continued U.S. Government Funding for HIV Testing
Trinity Biotech ( ($TRIB) ) has issued an announcement. Trinity Biotech announced a positive update regarding the U.S. government’s funding for ...
Investing8d
Trinity Biotech reports leap in CGM system accuracy
In other recent news, Trinity Biotech has been active on multiple fronts. The company secured continued U.S. government funding for its HIV testing programs, despite a broader review of foreign aid.
Yahoo Finance12d
Trinity Biotech plc (TRIB)
Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business ... a non-invasive test for monitoring the risk of aggressive prostate cancer. This ...